Workflow
建造配套服务
icon
Search documents
今海医疗科技盘中最低价触及0.550港元,创近一年新低
Sou Hu Cai Jing· 2025-08-15 09:03
Core Viewpoint - As of August 15, 2023, Jin Hai Medical Technology (02225.HK) experienced a significant decline in stock price, closing at HKD 0.890, down 50.56% from the previous trading day, with an intraday low of HKD 0.550, marking a new low for the past year [1] Group 1: Company Overview - Jin Hai Medical Technology Co., Ltd. (stock code: 2225) primarily operates as a service provider, with its subsidiary KT&T Group of Companies located in Singapore, offering labor dispatch and supporting services to local construction contractors [1] - The company has expanded its services beyond pure construction labor and resource provision to become a comprehensive solution provider for space management, including dormitory services, IT services, warehousing, cleaning, and building maintenance [1] Group 2: Business Strategy - The company aims to leverage the advantages of both Hong Kong and Singapore as platforms for external operations, actively seeking to expand existing businesses while entering new industries and exploring investment cooperation opportunities to enhance long-term returns for the company and its shareholders [1]
今海医疗科技(02225.HK)7月17日收盘上涨11.52%,成交726.49万港元
Sou Hu Cai Jing· 2025-07-17 08:36
Company Overview - Jinhai Medical Technology Co., Ltd. (stock code: 02225.HK) operates primarily in the service provider sector, offering labor dispatch and supporting services to construction contractors in Singapore, along with dormitory, IT, and construction support services [2] - The company aims to leverage its advantages in Hong Kong and Singapore to expand its existing business, enter new industries, and seek investment cooperation opportunities to enhance long-term returns for shareholders [2] Financial Performance - As of December 31, 2024, Jinhai Medical reported total revenue of 267 million yuan, representing a year-on-year growth of 10.07% [1] - The company recorded a net profit attributable to shareholders of -95.599 million yuan, a significant decrease of 471.95% compared to the previous year [1] - The gross profit margin stood at 22.84%, while the debt-to-asset ratio was 44.32% [1] Market Performance - On July 17, the Hang Seng Index closed down 0.08% at 24,498.95 points, while Jinhai Medical's stock price increased by 11.52% to 1.84 HKD per share, with a trading volume of 4.035 million shares and a turnover of 7.2649 million HKD [1] - Over the past month, Jinhai Medical's stock has seen a cumulative increase of 20.44%, but it has declined by 13.16% year-to-date, underperforming the Hang Seng Index by 22.22% [1] Valuation Metrics - Currently, there are no institutional investment ratings for Jinhai Medical [2] - The average price-to-earnings (P/E) ratio for the support services industry (TTM) is 3.73, with a median of 3.77 [2] - Jinhai Medical's P/E ratio is -82.63, ranking 57th in the industry, compared to other companies in the Chinese education sector with P/E ratios ranging from 1.47 to 2.8 [2] Corporate Actions - On July 13, 2025, the company plans to issue 120 million new shares, representing 2.27% of the enlarged share capital, at a subscription price of 1.35 HKD per share, which is a 17.68% discount to the previous closing price [3]